Inari VISION Registry

Recruiting

• Conditions: Pulmonary Embolism

• Registration Number: NCT06600542
• Lead Sponsor: Inari Medical

Brief Summary

This registry is a global prospective, non-randomized, multicenter, observational, active post-market data collection of Inari Medical devices and products.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2024-08-15
• Study First Submitted QC: 2024-09-16
• Study First Posted: 2024-09-19
• Study Start: 2025-03-07
• Status Verified: 2025-05
• Last Update Submitted: 2025-05-12
• Last Update Posted: 2025-05-14
• Primary Completion: 2029-12-31
• Study Completion: 2029-12-31

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 500

Inclusion Criteria

1. Willing and able to provide informed consent per institution and geographical requirements
2. Has received treatment with an eligible Inari Medical device. NOTE: If patients are consented prior to their procedure and the procedure does not take place, the patient will be considered a screen failure.
3. Currently within enrollment window relative to their procedure
4. Age ≥ 18 years

Exclusion Criteria

1. Is or will be inaccessible for registry follow-up
2. Meets exclusion criteria required by local requirements
3. Current or planned participation in another drug or device study that, in the investigator's opinion, would interfere with participation in this registry
4. Is pregnant or breastfeeding at the time of enrollment

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Incidence of device-related, procedure-related, or fatal Adverse Events	Up to 180 days

Trial Locations

Locations (3)

Queen Elizabeth University Hospital; 🇬🇧 Glasgow, United Kingdom

Royal Free Hospital; 🇬🇧 London, United Kingdom

UCLH University College London Hospital; 🇬🇧 London, United Kingdom